Cytoreductive nephron-sparing surgery do
β
Georg C. Hutterer; Jean-Jacques Patard; Marc Colombel; Arie S. Belldegrun; Chris
π
Article
π
2007
π
John Wiley and Sons
π
English
β 103 KB
π 2 views
## Abstract ## BACKGROUND. The role of nephronβsparing surgery (NSS) showed promise in patients with metastatic renal cell carcinoma (MRCC). The diseaseβspecific survival of patients with MRCC was compared according to the type of surgery, NSS (N = 45) versus radical nephrectomy (RN) (N = 732), in